Establishing a blueprint for nuclear pore complex assembly

建立核孔复合体组装蓝图

基本信息

  • 批准号:
    9250184
  • 负责人:
  • 金额:
    $ 31.54万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-08-01 至 2018-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Nuclear pore complexes (NPCs) provide the sole gateways that control the bidirectional exchange of molecules across the nuclear envelope (NE) in all eukaryotes. From the perspective of human health, compromised function of several of the components of the NPC (nucleoporins/nups) is associated with diverse diseases including cancers, heart disease, triple A syndrome, and neurodegenerative diseases like Alzheimer's and Parkinson's. Further, to propagate and promote infection, viruses often modulate nup function. The wide spectrum of these pathologies suggests that the NPC impacts a broad array of essential cellular processes, although the mechanisms are poorly defined. In addition, several nup genes are up- or down- regulated, and NPC number is altered, in developmental and disease contexts. Thus, a better understanding of mechanisms that contribute to NPC function will likely reveal translational drug targets in the future. While, as a field, we have a good understanding of the underlying mechanisms governing nuclear transport, a major remaining challenge is determining the mechanism of de novo NPC assembly. Specifically, it is not understood how the ~30 individual nups are coordinately assembled in space and time to form the ~50 MD NPC. Further, the assembly of individual nups coincides with the generation of membrane curvature that leads to the close apposition and eventual fusion of the inner and outer nuclear membranes to generate a nuclear pore. It is not known how nup assembly and membrane fusion are coordinated, nor has the fusion machinery been clearly identified. In this proposal, we aim to tackle two key challenges in understanding the assembly of the NPC. First, we propose an experimental strategy designed to elucidate the order by which nups are assembled at the NE during interphase. We will achieve this by exploiting the genetic toolkit of the yeast, S. cerevisiae, to generate a system where we rapidly and specifically inactivate newly synthesized nups one at a time, leaving mature NPCs unaffected. After inactivation of each target nup, we will comprehensively examine the distribution of other nups to assign an up- or down-stream relationship in the order of assembly. Integrating this data set, we will systematically define the steps in the assembly process. Second, we will use both the order analysis and a candidate approach to identify proteins that generate membrane curvature to support pore formation in the NE during NPC assembly. Using a series of in vivo and in vitro approaches, we will test whether these candidate curvature generators are capable of directly driving membrane curvature and home in on their curvature-generating domains. In this way, we will shed significant new light onto the molecular mechanisms of pore formation and directly test how membrane curvature impacts NPC assembly. The experiments outlined in this proposal will provide much needed mechanistic insight into the essential process of NPC biogenesis, universal to all eukaryotes.
描述(由申请人提供):核孔复合物(npc)在所有真核生物中提供控制分子在核包膜(NE)上双向交换的唯一通道。从人类健康的角度来看,NPC(核孔蛋白/核孔蛋白)的几个组成部分的功能受损与多种疾病有关,包括癌症、心脏病、aaa综合征和阿尔茨海默病和帕金森病等神经退行性疾病。此外,为了繁殖和促进感染,病毒经常调节nup功能。这些病理的广泛性表明鼻咽癌影响了广泛的基本细胞过程,尽管其机制尚不明确。此外,在发育和疾病背景下,一些nup基因被上调或下调,NPC数量被改变。因此,更好地了解NPC功能的机制可能会在未来揭示转化药物靶点。虽然,作为一个领域,我们已经很好地理解了控制核传输的潜在机制,但一个主要的挑战是确定从头开始的NPC组装机制。具体来说,目前还不清楚这30个独立的星云是如何在空间和时间上协调地组装成50个MD的NPC的。此外,单个核结的组装与膜曲率的产生相一致,从而导致内外核膜的紧密靠近和最终融合,从而产生核孔。目前尚不清楚nup组装和膜融合是如何协调的,也没有清楚地确定融合机制。在这个提案中,我们的目标是解决了解全国人大会议的两个主要挑战。首先,我们提出了一种实验策略,旨在阐明在间期期间nup在NE组装的顺序。我们将通过利用酵母的遗传工具包来实现这一目标,酿酒酵母,产生一个系统,在这个系统中,我们可以一次快速地特异性地灭活新合成的核苷酸,而不影响成熟的npc。在每个目标nup失活后,我们将全面检查其他nup的分布,以按照组装顺序分配上游或下游关系。整合此数据集,我们将系统地定义装配过程中的步骤。其次,我们将使用顺序分析和候选方法来识别在NPC组装过程中产生膜曲率以支持NE孔形成的蛋白质。使用一系列体内和体外方法,我们将测试这些候选曲率发生器是否能够直接驱动膜曲率并返回其曲率产生域。通过这种方式,我们将为孔形成的分子机制提供重要的新见解,并直接测试膜曲率如何影响NPC组装。本提案中概述的实验将为所有真核生物普遍存在的NPC生物发生的基本过程提供急需的机制见解。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Charles Patrick Lusk其他文献

Charles Patrick Lusk的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Charles Patrick Lusk', 18)}}的其他基金

The mechanism of nuclear autophagy
核自噬机制
  • 批准号:
    10688323
  • 财政年份:
    2022
  • 资助金额:
    $ 31.54万
  • 项目类别:
Nuclear pore complex quality control in ALS/FTD
ALS/FTD 中核孔复合物的质量控制
  • 批准号:
    10231741
  • 财政年份:
    2021
  • 资助金额:
    $ 31.54万
  • 项目类别:
Nuclear pore complex quality control in ALS/FTD
ALS/FTD 中核孔复合物的质量控制
  • 批准号:
    10842963
  • 财政年份:
    2021
  • 资助金额:
    $ 31.54万
  • 项目类别:
Nuclear pore complex quality control in ALS/FTD
ALS/FTD 中核孔复合物的质量控制
  • 批准号:
    10622792
  • 财政年份:
    2021
  • 资助金额:
    $ 31.54万
  • 项目类别:
Nuclear pore complex quality control in ALS/FTD
ALS/FTD 中核孔复合物的质量控制
  • 批准号:
    10615677
  • 财政年份:
    2021
  • 资助金额:
    $ 31.54万
  • 项目类别:
Nuclear pore complex quality control in ALS/FTD
ALS/FTD 中核孔复合物的质量控制
  • 批准号:
    10393661
  • 财政年份:
    2021
  • 资助金额:
    $ 31.54万
  • 项目类别:
Defining the Nucleophagy Mechanism: Opening New Doors for Aging Research
定义核吞噬机制:为衰老研究打开新的大门
  • 批准号:
    9761417
  • 财政年份:
    2018
  • 资助金额:
    $ 31.54万
  • 项目类别:
The mechanism of ESCRT-mediated surveillance of the nuclear envelope barrier
ESRT 介导的核膜屏障监测机制
  • 批准号:
    9923678
  • 财政年份:
    2013
  • 资助金额:
    $ 31.54万
  • 项目类别:
The mechanism of ESCRT-mediated surveillance of the nuclear envelope barrier
ESRT 介导的核膜屏障监测机制
  • 批准号:
    10467117
  • 财政年份:
    2013
  • 资助金额:
    $ 31.54万
  • 项目类别:
The mechanism of ESCRT-mediated surveillance of the nuclear envelope barrier
ESRT 介导的核膜屏障监测机制
  • 批准号:
    10797408
  • 财政年份:
    2013
  • 资助金额:
    $ 31.54万
  • 项目类别:

相似国自然基金

新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
  • 批准号:
    81000622
  • 批准年份:
    2010
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
  • 批准号:
    31060293
  • 批准年份:
    2010
  • 资助金额:
    26.0 万元
  • 项目类别:
    地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
  • 批准号:
    30960334
  • 批准年份:
    2009
  • 资助金额:
    22.0 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
  • 批准号:
    10657993
  • 财政年份:
    2023
  • 资助金额:
    $ 31.54万
  • 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
  • 批准号:
    10381163
  • 财政年份:
    2022
  • 资助金额:
    $ 31.54万
  • 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
  • 批准号:
    10531959
  • 财政年份:
    2022
  • 资助金额:
    $ 31.54万
  • 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
  • 批准号:
    10700991
  • 财政年份:
    2022
  • 资助金额:
    $ 31.54万
  • 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
  • 批准号:
    10518582
  • 财政年份:
    2022
  • 资助金额:
    $ 31.54万
  • 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
  • 批准号:
    10672973
  • 财政年份:
    2022
  • 资助金额:
    $ 31.54万
  • 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
  • 批准号:
    10585925
  • 财政年份:
    2022
  • 资助金额:
    $ 31.54万
  • 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
  • 批准号:
    10180000
  • 财政年份:
    2021
  • 资助金额:
    $ 31.54万
  • 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
  • 批准号:
    10049426
  • 财政年份:
    2021
  • 资助金额:
    $ 31.54万
  • 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
  • 批准号:
    10295809
  • 财政年份:
    2021
  • 资助金额:
    $ 31.54万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了